ArticleNPJ breast cancer2026

Identifying the window of aggressive postpartum breast cancer based on the 21-gene Oncotype DX® test in women with HR+, HER2-negative breast cancer.

Shiliang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.